207 related articles for article (PubMed ID: 36689929)
1. Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis.
Osaki M; Arai T; Sumikawa H; Takimoto T; Takeuchi N; Tamiya A; Okishio K; Inoue Y
Oncology; 2023; 101(5):303-312. PubMed ID: 36689929
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of radiological pleuroparenchymal fibroelastosis pattern in interstitial lung disease patients registered for lung transplantation: a retrospective cohort study.
Tanizawa K; Handa T; Kubo T; Chen-Yoshikawa TF; Aoyama A; Motoyama H; Hijiya K; Yoshizawa A; Oshima Y; Ikezoe K; Tokuda S; Nakatsuka Y; Murase Y; Nagai S; Muro S; Oga T; Chin K; Hirai T; Date H
Respir Res; 2018 Aug; 19(1):162. PubMed ID: 30165854
[TBL] [Abstract][Full Text] [Related]
3. Pleuroparenchymal fibroelastosis in rheumatoid arthritis-associated interstitial lung disease.
Kang J; Seo WJ; Lee EY; Chang SH; Choe J; Hong S; Song JW
Respir Res; 2022 Jun; 23(1):143. PubMed ID: 35655303
[TBL] [Abstract][Full Text] [Related]
4. Pleuroparenchymal fibroelastosis.
Cottin V; Si-Mohamed S; Diesler R; Bonniaud P; Valenzuela C
Curr Opin Pulm Med; 2022 Sep; 28(5):432-440. PubMed ID: 35855575
[TBL] [Abstract][Full Text] [Related]
5. Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer.
Yamagata A; Yokoyama T; Fukuda Y; Ishida T
Cancer Chemother Pharmacol; 2021 Feb; 87(2):251-258. PubMed ID: 33394102
[TBL] [Abstract][Full Text] [Related]
6. Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease.
Enomoto Y; Nakamura Y; Colby TV; Johkoh T; Sumikawa H; Nishimoto K; Yoshimura K; Matsushima S; Oyama Y; Hozumi H; Kono M; Fujisawa T; Enomoto N; Inui N; Iwashita T; Suda T
PLoS One; 2017; 12(6):e0180283. PubMed ID: 28666014
[TBL] [Abstract][Full Text] [Related]
7. Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias.
Fujisawa T; Horiike Y; Egashira R; Sumikawa H; Iwasawa T; Matsushita S; Sugiura H; Kataoka K; Hashisako M; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
Respir Res; 2021 Nov; 22(1):290. PubMed ID: 34758816
[TBL] [Abstract][Full Text] [Related]
8. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Respir Investig; 2019 Sep; 57(5):451-459. PubMed ID: 31248832
[TBL] [Abstract][Full Text] [Related]
9. Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease.
Sarı A; Önder Ö; Armağan B; Bölek EÇ; Farisoğulları B; Bilgin E; Yardımcı GK; Arıyürek M; Akdoğan A
Turk J Med Sci; 2022 Feb; 52(1):83-88. PubMed ID: 36161593
[TBL] [Abstract][Full Text] [Related]
10. Outcome and risk factor of immune-related adverse events and pneumonitis in patients with advanced or postoperative recurrent non-small cell lung cancer treated with immune checkpoint inhibitors.
Isono T; Kagiyama N; Takano K; Hosoda C; Nishida T; Kawate E; Kobayashi Y; Ishiguro T; Takaku Y; Kurashima K; Yanagisawa T; Takayanagi N
Thorac Cancer; 2021 Jan; 12(2):153-164. PubMed ID: 33201587
[TBL] [Abstract][Full Text] [Related]
11. Clinical, radiological and pathological features of idiopathic and secondary interstitial pneumonia with pleuroparenchymal fibroelastosis in patients undergoing lung transplantation.
Ikegami N; Nakajima N; Yoshizawa A; Handa T; Chen-Yoshikawa T; Kubo T; Tanizawa K; Ohsumi A; Yamada Y; Hamaji M; Nakajima D; Yutaka Y; Tanaka S; Watanabe K; Nakatsuka Y; Murase Y; Nakanishi T; Niwamoto T; Chin K; Date H; Hirai T
Histopathology; 2022 Mar; 80(4):665-676. PubMed ID: 34747513
[TBL] [Abstract][Full Text] [Related]
12. Pleuroparenchymal fibroelastosis-like lesions in patients with interstitial pneumonia diagnosed by multidisciplinary discussion with surgical lung biopsy.
Sumikawa H; Johkoh T; Egashira R; Sugiura H; Yamano Y; Kataoka K; Kondoh Y; Arakawa H; Nakamura M; Kuriu A; Nakanishi K; Tomiyama N
Eur J Radiol Open; 2020; 7():100298. PubMed ID: 33354595
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Characteristics and Outcomes between Idiopathic and Secondary Pleuroparenchymal Fibroelastosis.
Oda T; Sekine A; Tabata E; Iwasawa T; Takemura T; Ogura T
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670776
[TBL] [Abstract][Full Text] [Related]
14. Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor-Induced Interstitial Lung Disease Among Patients With Nonlung Cancers.
Shimoji K; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Takeno S; Hide M; Teishima J; Ohdan H; Hattori N
JAMA Netw Open; 2020 Nov; 3(11):e2022906. PubMed ID: 33180128
[TBL] [Abstract][Full Text] [Related]
15. Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer.
Wong A; Riley M; Zhao S; Zimmer J; Viveiros M; Wang JG; Esguerra V; Li M; Lopez G; Kendra K; Carbone DP; He K; Alahmadi A; Kaufman J; Memmott RM; Shields PG; Brownstein J; Haglund K; Welliver M; Otterson GA; Presley CJ; Wei L; Owen DH; Ho K
J Natl Compr Canc Netw; 2023 Nov; 21(11):1164-1171.e5. PubMed ID: 37935100
[TBL] [Abstract][Full Text] [Related]
16. Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases.
Kinoshita Y; Watanabe K; Ishii H; Kushima H; Hamasaki M; Fujita M; Nabeshima K
Virchows Arch; 2019 Jan; 474(1):97-104. PubMed ID: 30327882
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis.
d'Alessandro M; Bellisai F; Bergantini L; Cameli P; D'Alessandro R; Mazzei MA; Gentili F; Conticini E; Selvi E; Frediani B; Matucci-Cerinic M; Bargagli E
Eur J Clin Invest; 2021 Aug; 51(8):e13543. PubMed ID: 33759179
[TBL] [Abstract][Full Text] [Related]
18. Pleuroparenchymal fibroelastosis after hematopoietic stem cell transplantation in children: a propensity score-matched analysis.
Oh SL; Lee JW; Yoo SY; Kim JH; Kim YJ; Han J; Kim K; Kim J; Jeon TY
Eur Radiol; 2023 Mar; 33(3):2266-2276. PubMed ID: 36346442
[TBL] [Abstract][Full Text] [Related]
19. Whole-lung pathology of pleuroparenchymal fibroelastosis (PPFE) in an explanted lung: Significance of elastic fiber-rich, non-specific interstitial pneumonia-like change in chemotherapy-related PPFE.
Tsubosaka A; Matsushima J; Ota M; Suzuki M; Yonemori Y; Ota S; Yoshino I; Tsushima K; Tatsumi K; Nakatani Y
Pathol Int; 2019 Sep; 69(9):547-555. PubMed ID: 31290582
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
Respir Med; 2019; 154():122-126. PubMed ID: 31238182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
